Rachael McGovern
- BIOGRAPHY
- Insights
Rachael McGovern is a member of our Applied Behavioral Analysis and Medical and Education Services, Real Estate and Construction, Corporation/Mergers and Acquisitions, and Regulator Health Care Law Practice Groups. Rachael advises clients on regulatory compliance and corporate transactional matters. She represents hospitals, ambulatory surgery centers (ASCs), diagnostic imaging facilities, independent physician and dental practices, behavioral health (ABA) providers, and both for-profit and not-for-profit organizations. She counsels clients on employment and equity ownership agreements, corporate practice of medicine (CPOM) issues, state licensure and scope of practice questions, asset purchase agreements, changes of ownership (CHOWs), and health care regulatory and compliance matters. Rachael advises clients on commercial real estate and lease negotiations, risk mitigation, and landlord-tenant matters. She also conducts health care due diligence for major corporate transactions, helping clients assess compliance obligations under state and federal health care laws.
Prior to joining the firm, Rachael worked at a boutique corporate law firm in New York where she handled general corporate transactional work, including state licensure for professional corporations and restaurants (liquor licenses), real estate and purchase transactions, and the formation of both for-profit and not-for-profit entities.
During law school, Rachael served as a student attorney in the Amelia A. Gould Representation in Mediation Clinic under a New York State Practice Order, where she provided pro bono advice to pro se litigants in court-ordered mediations in the Southern District of New York and the Surrogate’s Court of Westchester County.
Providers delivering behavioral and therapeutic services to New Jersey FamilyCare members must complete a new FBI fingerprint-based background check, or risk being ineligible to provide services.
Every employee separation in New Jersey, from resignations to layoffs, must now be reported electronically through the Department of Labor’s Employer Access Portal. This means employers must proactively report separations, including terminations, resignations, layoffs, retirements, and other forms of job separation – regardless of whether the employee files for unemployment benefits.
Applied Behavior Analysis therapy providers operating clinic-based environments in New York City and New York State have recently experienced increased scrutiny and enforcement actions from different regulatory authorities, including the New York State Office of Children and Family Services, and the New York City Department of Health and Mental Hygiene.
Following months of uncertainty surrounding the future of the Corporate Transparency Act's (CTA) beneficial ownership information (BOI) reporting requirements, the U.S. Department of the Treasury, Financial Crimes Enforcement Network (FinCEN) published an interim final rule (Interim Rule) on March 21, 2025 that removes the requirement for U.S. companies and U.S. persons to submit BOI reports to FinCEN under the CTA.
In a surprising new development that comes just days after a temporary ban on the Corporate Transparency Act's (CTA) beneficial ownership information (BOI) reporting requirements was lifted, the U.S. Department of the Treasury (Treasury Department), Financial Crimes Enforcement Network (FinCEN) announced in a March 2nd press release that it will not enforce the BOI reporting requirements against U.S. citizens and domestic reporting companies.
Following nearly a year of legal challenges, the beneficial ownership information (BOI) reporting requirements under the Corporate Transparency Act (CTA) are once again back in effect, with a current filing deadline of March 21, 2025.
In a recent ruling, the New Jersey Supreme Court concluded that the “self-critical analysis” privilege under the Patient Safety Act (“PSA”) and its implementing regulations can only be applicable if the information sought was generated for purposes of an independent patient safety committee that is created solely for the purposes of the PSA (i.e., the information […]
Pursuant to the New Jersey Applied Behavior Analyst Licensing Act (the “Act”), the Board of Applied Behavior Analyst Examiners (the “Board”) published the official rules concerning the practice of Applied Behavior Analyst (“ABA”) therapy, effective May 6, 2024 (the “Rules”).
On March 1, 2024, the United States District Court for the Northern District of Alabama declared the Corporate Transparency Act (CTA) unconstitutional.
Rachael McGovern is a member of our Applied Behavioral Analysis and Medical and Education Services, Real Estate and Construction, Corporation/Mergers and Acquisitions, and Regulator Health Care Law Practice Groups. Rachael advises clients on regulatory compliance and corporate transactional matters. She represents hospitals, ambulatory surgery centers (ASCs), diagnostic imaging facilities, independent physician and dental practices, behavioral health (ABA) providers, and both for-profit and not-for-profit organizations. She counsels clients on employment and equity ownership agreements, corporate practice of medicine (CPOM) issues, state licensure and scope of practice questions, asset purchase agreements, changes of ownership (CHOWs), and health care regulatory and compliance matters. Rachael advises clients on commercial real estate and lease negotiations, risk mitigation, and landlord-tenant matters. She also conducts health care due diligence for major corporate transactions, helping clients assess compliance obligations under state and federal health care laws.
Prior to joining the firm, Rachael worked at a boutique corporate law firm in New York where she handled general corporate transactional work, including state licensure for professional corporations and restaurants (liquor licenses), real estate and purchase transactions, and the formation of both for-profit and not-for-profit entities.
During law school, Rachael served as a student attorney in the Amelia A. Gould Representation in Mediation Clinic under a New York State Practice Order, where she provided pro bono advice to pro se litigants in court-ordered mediations in the Southern District of New York and the Surrogate’s Court of Westchester County.
Pursuant to the New Jersey Applied Behavior Analyst Licensing Act (the “Act”), the Board of Applied Behavior Analyst Examiners (the “Board”) published the official rules concerning the practice of Applied Behavior Analyst (“ABA”) therapy, effective May 6, 2024 (the “Rules”).
On March 1, 2024, the United States District Court for the Northern District of Alabama declared the Corporate Transparency Act (CTA) unconstitutional.
In a recent ruling, the New Jersey Supreme Court concluded that the “self-critical analysis” privilege under the Patient Safety Act (“PSA”) and its implementing regulations can only be applicable if the information sought was generated for purposes of an independent patient safety committee that is created solely for the purposes of the PSA (i.e., the information […]
Following nearly a year of legal challenges, the beneficial ownership information (BOI) reporting requirements under the Corporate Transparency Act (CTA) are once again back in effect, with a current filing deadline of March 21, 2025.
In a surprising new development that comes just days after a temporary ban on the Corporate Transparency Act's (CTA) beneficial ownership information (BOI) reporting requirements was lifted, the U.S. Department of the Treasury (Treasury Department), Financial Crimes Enforcement Network (FinCEN) announced in a March 2nd press release that it will not enforce the BOI reporting requirements against U.S. citizens and domestic reporting companies.
Following months of uncertainty surrounding the future of the Corporate Transparency Act's (CTA) beneficial ownership information (BOI) reporting requirements, the U.S. Department of the Treasury, Financial Crimes Enforcement Network (FinCEN) published an interim final rule (Interim Rule) on March 21, 2025 that removes the requirement for U.S. companies and U.S. persons to submit BOI reports to FinCEN under the CTA.
Applied Behavior Analysis therapy providers operating clinic-based environments in New York City and New York State have recently experienced increased scrutiny and enforcement actions from different regulatory authorities, including the New York State Office of Children and Family Services, and the New York City Department of Health and Mental Hygiene.
Providers delivering behavioral and therapeutic services to New Jersey FamilyCare members must complete a new FBI fingerprint-based background check, or risk being ineligible to provide services.
Every employee separation in New Jersey, from resignations to layoffs, must now be reported electronically through the Department of Labor’s Employer Access Portal. This means employers must proactively report separations, including terminations, resignations, layoffs, retirements, and other forms of job separation – regardless of whether the employee files for unemployment benefits.
Every employee separation in New Jersey, from resignations to layoffs, must now be reported electronically through the Department of Labor’s Employer Access Portal. This means employers must proactively report separations, including terminations, resignations, layoffs, retirements, and other forms of job separation – regardless of whether the employee files for unemployment benefits.
Providers delivering behavioral and therapeutic services to New Jersey FamilyCare members must complete a new FBI fingerprint-based background check, or risk being ineligible to provide services.
Applied Behavior Analysis therapy providers operating clinic-based environments in New York City and New York State have recently experienced increased scrutiny and enforcement actions from different regulatory authorities, including the New York State Office of Children and Family Services, and the New York City Department of Health and Mental Hygiene.
Following months of uncertainty surrounding the future of the Corporate Transparency Act's (CTA) beneficial ownership information (BOI) reporting requirements, the U.S. Department of the Treasury, Financial Crimes Enforcement Network (FinCEN) published an interim final rule (Interim Rule) on March 21, 2025 that removes the requirement for U.S. companies and U.S. persons to submit BOI reports to FinCEN under the CTA.
In a surprising new development that comes just days after a temporary ban on the Corporate Transparency Act's (CTA) beneficial ownership information (BOI) reporting requirements was lifted, the U.S. Department of the Treasury (Treasury Department), Financial Crimes Enforcement Network (FinCEN) announced in a March 2nd press release that it will not enforce the BOI reporting requirements against U.S. citizens and domestic reporting companies.
Following nearly a year of legal challenges, the beneficial ownership information (BOI) reporting requirements under the Corporate Transparency Act (CTA) are once again back in effect, with a current filing deadline of March 21, 2025.
In a recent ruling, the New Jersey Supreme Court concluded that the “self-critical analysis” privilege under the Patient Safety Act (“PSA”) and its implementing regulations can only be applicable if the information sought was generated for purposes of an independent patient safety committee that is created solely for the purposes of the PSA (i.e., the information […]
Pursuant to the New Jersey Applied Behavior Analyst Licensing Act (the “Act”), the Board of Applied Behavior Analyst Examiners (the “Board”) published the official rules concerning the practice of Applied Behavior Analyst (“ABA”) therapy, effective May 6, 2024 (the “Rules”).
On March 1, 2024, the United States District Court for the Northern District of Alabama declared the Corporate Transparency Act (CTA) unconstitutional.
Practices
Education
- Advanced Certificate in Health Law & Policy
Court admissions
PROFESSIONAL MEMBERSHIPS
- New York City Bar Association’s Air and Space Law Committee (2024-2027)
- New York City Bar Association
- Irish American Bar Association of New York
- New Jersey Bar Association
AWARDS & RANKINGS
Pace University School of Law, Excellence in Clinical Education Award, 2021-2022